Coronary artery bypass graft (CABG) operations have
|
|
- Wilfred Crawford
- 6 years ago
- Views:
Transcription
1 Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care Research Unit, Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts Background. Little is known about regional patterns of intraaortic balloon pump (IABP) use in coronary artery bypass graft (CABG) operations. Our objectives were (1) to identify clinical variables associated with IABP use, and (2) to examine risk-adjusted rates of IABP use for 12 Massachusetts hospitals performing CABG operations. Methods. We used hospital discharge data to identify 6944 CABG surgical cases. Logistic regression was used to identify clinical variables associated with IABP use, and the resulting multivariate model was then used to risk adjust hospital rates of IABP use. Results. The IABP was used in 13.4% of the CABG surgical cases. The clinical variables independently associated with IABP use were cardiogenic shock, same admission angioplasty, prior CABG operation, cardiac arrest, congestive heart failure, recent myocardial infarction, and urgent admission status. Risk-adjusted rates of IABP use varied widely across hospitals from 7.8% to 20.8% (p < ). Conclusions. Hospital rates of IABP use vary considerably in Massachusetts. This practice variation may be related to the persistent uncertainty regarding the precise clinical indications for the IABP in this patient population. (Ann Thorac Surg 1999;67:441 5) 1999 by The Society of Thoracic Surgeons Coronary artery bypass graft (CABG) operations have been the focus of several studies evaluating outcomes of care. Many of these studies have demonstrated regional and between-hospital variability in postoperative outcomes that are not explained by adjusting for patients baseline clinical characteristics [1 4]. Such variation in outcomes across providers raises the possibility of differences in quality of care across regions and hospitals. These findings have prompted calls [5, 6] for more research focusing on process of care variables rather than just outcomes to identify factors that contribute to variation in outcomes across providers. Intraaortic balloon pump (IABP) use in CABG operation is an important process variable that may vary across hospitals and affect patient outcomes. The IABP has established physiologic benefits in patients with compromised cardiac function [7], and underuse of this technology has the potential to produce poor patient outcomes. However, IABP use itself can lead to complications (eg, infection, hemorrhage, peripheral embolism, aortic rupture) in as many as 15% to 20% of cases [8, 9]. Overuse of the IABP therefore also has the potential to produce poor patient outcomes. Little is known about regional patterns of IABP use, and whether rates of use are consistent across providers an important question considering the potential impact of this technology on patient outcomes. Our objectives were (1) to identify clinical and sociodemographic variables associated with IABP use, and (2) Accepted for publication July 6, Address reprint requests to Dr Ghali, Faculty of Medicine, University of Calgary, 3330 Hospital Dr NW, Calgary, Alberta, Canada, T2N 4N1 ( to use a multivariate model to examine risk-adjusted rates of IABP use across Massachusetts hospitals performing CABG operations. Material and Methods Data Source We used a statewide database maintained by the Massachusetts Health Data Consortium to identify all CABG surgical cases in Massachusetts in the fiscal year 1994 (October 1, 1993, through September 30, 1994). The database contains one record for each hospital discharge in Massachusetts [10], and each inpatient record contains up to 15 International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnoses and 15 procedure codes [11]. The records also contain information on patient age, sex, race, payer (eg, Medicaid, Medicare, health maintenance organization [HMO]), length of stay, admission type (elective, urgent, emergent), and diagnosis related group (DRG) [12]. Derivation of Study Cohort We identified CABG surgical cases by screening all hospital discharge abstracts for ICD-9-CM procedure codes representing CABG operations (36.10 through 36.19). This case selection criterion captured all patients who had a simple CABG procedure, as well as those who had a combined CABG plus valve procedure. Cases outside of DRGs 104 through 108 and 483 were excluded (n 42) because the clinically dissimilar cases assigned to other DRGs usually involved hospitalizations with other noncardiac surgical procedures. Cases in DRG by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (98)
2 442 GHALI ET AL Ann Thorac Surg BALLOON PUMP USE IN BYPASS OPERATION 1999;67:441 5 (denoting tracheostomy) were reclassified to the DRG category (104 through 108) to which they would have been assigned had tracheostomy not occurred. All cases from a single Veterans Affairs hospital were also excluded because of important data inconsistencies. This case selection process yielded a study cohort of 6,944 CABG surgical cases performed in 12 hospitals. The volume of cases per hospital ranged from a low of 330 to a high of 946. Definitions of Study Variables The process variable of interest was IABP use, defined by the presence of ICD-9-CM procedure code Because we could not distinguish between preoperative and postoperative IABP use in our database, the focus of this study is on overall hospital rates of IABP use. A number of other variables were assessed as potential correlates of IABP use. These were grouped into three categories: sociodemographic, comorbidity, and disease-specific variables. The sociodemographic variables were age, sex, race (white versus other), and socioeconomic status (defined as low for cases in which care was free or the payer was Medicaid). Fifteen comorbidity variables (eg, diabetes, peripheral vascular disease, cerebrovascular disease, chronic lung disease) were defined using an ICD-9-CM coding algorithm derived by Deyo and colleagues [13]. We then used these comorbidity variables to assign a comorbidity score to each CABG surgical case. The score consisted of the 17-variable Charlson index [14], altered by removing two disease-specific variables (congestive heart failure and myocardial infarction), which were evaluated separately. The disease-specific variables and corresponding ICD- 9-CM code definitions were congestive heart failure (ICD-9-CM code 428), recent myocardial infarction (410.0x through 410.9x), prior CABG operation (v458.1), angioplasty on the same admission (procedure codes 36.01, 36.03, or 36.09), acquired ventricular septal defect (429.71), ruptured chordae tendinae (429.5 or 429.6), cardiogenic shock (785.51), and cardiac arrest (427.4, 427.5, , or ). Combined CABG plus valve procedures were identified by patient assignments to DRGs 104 and 105. Urgent admission status (ie, urgent or emergent admission as opposed to elective) was determined from admission type. Analysis We used 2 and Fisher s exact tests, when appropriate, to test potential associations between IABP use and each of the variables defined above. From the results of these bivariate analyses, we selected variables that appeared in at least 10 cases and showed even weak ( p 0.15) associations with IABP use for presentation to a logistic regression model. In our multivariate analysis, we retained only variables significantly associated with IABP use ( p 0.05). We assessed the resulting multivariate model s discrimination for predicting IABP use with the c statistic, which equals the area under the receiver operating Table 1. Characteristics of the 1994 Coronary Artery Bypass Graft Surgical Cohort (n 6,944). Characteristic Number % White 6, Urgent admission status 4, Age older than 65 years 4, Unstable angina 2, Female 2, Recent myocardial infarction 1, Congestive heart failure 1, Combined CABG plus valve procedure Same admission angioplasty Prior CABG operation Low socioeconomic status Cardiac arrest Cardiogenic shock Acquired ventricular septal defect Ruptured chordae tendinae Modified Charlson comorbidity score % with score 0 3, % with score 1 2, % with score % with score Intraaortic balloon pump use In-hospital mortality CABG coronary artery bypass graft. characteristic curve. Model calibration was assessed using the Hosmer-Lemeshow test of goodness-of-fit across categories of predicted risk. We then used the model to calculate risk-adjusted rates of IABP use for each of the 12 Massachusetts hospitals performing CABG operations as follows. First, we calculated the hospitals observed and expected rates of IABP use, and calculated each hospital s ratio of observed-to-expected use. We then multiplied this ratio by the statewide rate of use to yield a risk-adjusted rate. Because it is not clear whether higher or lower rates of IABP use are better (unlike mortality where lower is clearly better), we did not seek to identify outlier hospitals. Rather, we present the full range of IABP rates along with the extremal quotient (ratio of highest rate divided by lowest rate) and the coefficient of variation (ratio of the standard deviation of hospital rates divided by the average hospital rate) to quantify the degree of variation. We used a 2 test with 11 degrees of freedom to assess the statistical significance of the differences in risk-adjusted IABP rates across hospitals. This was achieved by evaluating the increment in our logistic model s 2 log likelihood 2 statistic when dummy variables for the hospital were added to the model. Results Table 1 presents the baseline characteristics of the 6,944 CABG surgical cases studied. Mean age was 66.0 years, and 62.8% were admitted urgently. The overall statewide
3 Ann Thorac Surg GHALI ET AL 1999;67:441 5 BALLOON PUMP USE IN BYPASS OPERATION 443 Table 2. Bivariate Associations of Intraaortic Balloon Pump Use in Coronary Artery Bypass Graft Operations Clinical Characteristic % IABP Use When Present % IABP Use When Absent p Value a Age older than 65 years Urgent admission status Female White Low socioeconomic status Unstable angina Recent myocardial infarction Congestive heart failure CABG plus valve (vs CABG only) Prior CABG operation Same admission angioplasty Cardiac arrest Cardiogenic shock Ruptured chordae tendinae Acquired ventricular septal defect Comorbidity Modified Charlson score Modified Charlson score Modified Charlson score Modified Charlson score a p values were calculated using 2 tests for bivariate associations. CABG coronary artery bypass graft; IABP intraaortic balloon pump. rate of IABP use was 13.4%. The statewide in-hospital mortality rate was 3.9%. Correlates of Intraaortic Balloon Pump Use Table 2 shows bivariate associations between individual clinical variables and IABP use. Among the sociodemographic variables assessed, only age and sex were significantly associated with IABP use. A number of diseasespecific variables were also significantly associated with IABP use: urgent admission status, recent myocardial infarction, congestive heart failure, prior CABG operation, same admission angioplasty, cardiac arrest, cardiogenic shock, ruptured chordae tendinae, and acquired ventricular defect. Intraaortic balloon pump use varied significantly ( p 0.001) according to patients modified Charlson comorbidity index scores, but there was no trend in IABP use as comorbidity scores increased. Patients treated with the IABP were more likely to die than patients who did not receive this treatment (16.4% inhospital mortality for IABP cases versus 1.9% for cases with no IABP; p 0.001). On multivariate analysis (Table 3), only seven variables were retained as significant ( p 0.05) correlates of IABP use. These variables were all from our predefined category of disease-specific variables. The Charlson comorbidity index score, modeled either as a continuous or a categorical variable, did not enter this model, nor did a number of other significant variables from the bivariate Table 3. Multivariate Model Predicting Intraaortic Balloon Pump Use in Coronary Artery Bypass Graft Operations a Variable Beta Coefficient Odds Ratio 95% Confidence Interval Intercept Cardiogenic shock ( ) Same admission angioplasty ( ) Prior CABG operation ( ) Cardiac arrest ( ) Congestive heart failure ( ) Recent myocardial ( ) infarction Urgent admission status ( ) a Forward stepwise logistic regression model. Criteria for entry: n 10 in the data base and p 0.15 on bivariate analysis. Criterion for retention: p 0.05 to remain in final model. The model c statistic is 0.74 and the Hosmer-Lemeshow test does not reject the goodness-of-fit ( p 0.08). CABG coronary artery bypass graft. analysis (Table 2 versus Table 3). The seven clinical variables independently associated with IABP use were cardiogenic shock (odds ratio [OR] 19.5), same admission angioplasty (OR 4.4), prior CABG operation (OR 2.6), cardiac arrest (OR 2.4), congestive heart failure (OR 2.2), recent myocardial infarction (OR 1.8), and urgent admission status (OR 1.7). The resulting logistic regression model predicts well, with good discrimination (c 0.74) and calibration (Hosmer-Lemeshow test, p 0.08). On the Hosmer-Lemeshow test, the rates of actual IABP use in the highest and lowest predicted risk groupings were 37.9% and 4.0%, respectively (an almost tenfold risk difference). Hospital Rates of Intraaortic Balloon Pump Use Figure 1 presents unadjusted and adjusted rates of IABP use in the 12 Massachusetts hospitals studied. Hospital rates of IABP use varied widely from a low of 7.0% to a high of 24.9% in the unadjusted analysis, and from 7.8% to 20.8%, adjusted. The difference in adjusted rates of IABP use across hospitals was statistically significant ( with 11 degrees of freedom; p ). The extremal quotient for the difference across hospitals is 2.7, and the coefficient of variation is considerable at 0.354, or 35.4%. Risk adjustment of hospital rates of IABP use was in fact necessary, because model-predicted rates of IABP use varied significantly ( p 0.001) across hospitals, ranging from a low of 11.5% to a high of 15.9%. Reflected in these predicted rates is variation across hospitals in the prevalence of individual predictor variables. For example, the prevalence of cardiogenic shock varied from 0.3% in one hospital to 5.5% in another ( p for the difference in prevalence across hosptials). Likewise, the prevalence of congestive heart failure varied across hospitals from 13.9% to 26.0% ( p 0.001). Similar interhospital variation was seen for each of the risk variables included in our risk adjustment model ( p for all variables listed in Table 3).
4 444 GHALI ET AL Ann Thorac Surg BALLOON PUMP USE IN BYPASS OPERATION 1999;67:441 5 Fig 1. Unadjusted and adjusted rates of intraaortic balloon pump (IABP) use in 12 Massachusetts hospitals performing coronary artery bypass graft operations. Comment We have identified a number of clinical variables that correlate with IABP use in CABG operations, and despite adjusting for these variables have found wide variation in hospital rates of IABP use. This is an important finding because IABP use is a process variable with the potential to have both a positive and negative impact on patients clinical outcomes after CABG operations. The multivariate correlates of IABP use (Table 3) all fall within our predefined category of disease-specific variables. This suggests that it is clinical parameters relating to cardiac disease that have the greatest influence on clinicians decisions to use the IABP. Interestingly, burden of comorbidity (measured by the Charlson comorbidity index [13, 14]) was not independently associated with IABP use. Reassuringly, sociodemographic variables were not independently associated with IABP use. This contrasts with published findings of lower use of cardiac procedures in women (versus men) [15, 16], blacks (versus whites) [17], and Medicaid (versus insured) patients [18]. Our findings thus indicate that once a patient has been selected for CABG operation, the IABP appears to be used equally regardless of patients age, sex, race, and socioeconomic status. Most published articles reviewing clinical indications for IABP use distinguish between preoperative and intraoperative or postoperative indications [19 22]. There is little controversy about the clinical indications for intraoperative and postoperative IABP use. These are (1) inability to wean patients from cardiopulmonary bypass within 30 minutes of completing the operation, (2) poor hemodynamic status (systolic blood pressure 80 mm Hg, left ventricular end-diastolic pressure 20 mm Hg) despite inotropic therapy and vasodilators, (3) persistent requirements for inotropic therapy, and (4) arrhythmias attributable to cardiac ischemia. In contrast, there is considerable disagreement regarding preoperative indications. Some authors [19, 20] advocate use of the IABP for the following indications: (1) acute myocardial infarction with new mechanical defect (ventricular septal defect or acute mitral regurgitation), (2) cardiogenic shock, (3) left main coronary artery stenosis, (4) impaired left ventricular function, and (5) preoperative unstable angina. Others [21, 22] have questioned the need for IABP use in patients with the latter three indications. In arguing against widespread preoperative IABP use, they report that many patients with left main coronary artery stenosis, poor ventricular function, and unstable angina do well without the IABP. The question of patient selection for preoperative IABP use remains unresolved. A recent retrospective analysis of patients undergoing CABG operation with ejection fraction of 25% suggests benefit from IABP use, but the study was not randomized, and controls differed considerably from IABP-treated patients [23]. A randomized controlled trial is needed to definitively assess the efficacy of preoperative IABP use for selected patients undergoing CABG operation. This controversy about indications for IABP use may be responsible for the apparent practice variation in Massachusetts. Indeed, others [24] have found the largest surgical rate variations when procedural indications are unclear (ie, clear indications result in less variation). Wennberg [25] has stated that variations occur because the profession lacks consensus on the correct way to practice medicine, and that clinical research should target those interventions for which there is greatest variation. Our data do not clarify which rate of IABP use is right.
5 Ann Thorac Surg GHALI ET AL 1999;67:441 5 BALLOON PUMP USE IN BYPASS OPERATION 445 Although IABP-treated patients were more likely to die and to experience postoperative complications (data not shown), this probably reflects the fact that patients who received the IABP were initially sicker. We also cannot tell whether the differences in rates of IABP use arise from preoperative or postoperative practice variation. This latter question needs to be examined in databases that distinguish between preoperative and intraoperative or postoperative IABP insertion. Another important limitation of our study is our use of ICD-9-CM administrative data. Concerns with such data include the possibilities of undercoding of certain data elements and variable coding practices across hospitals. Furthermore, administrative data lack important clinical variables, which may explain at least some of the observed practice variation. For example, a greater proportion of the variation in hospital rates of IABP use might have been explained had we been able to adjust hospital IABP rates for clinical variables such as left ventricular ejection fraction or end-diastolic pressures. Reassuringly, despite these concerns, we were nonetheless able to develop and apply a clinically plausible multivariate model (Table 3) that is strongly predictive. We encourage investigators with access to more detailed regional clinical databases to see whether our findings can be replicated after adjustment for additional clinical variables such as ejection fraction. Despite these limitations, this study identifies clinical correlates of IABP use and finds significant variation in hospital rates of IABP use. Further work is now needed to clarify the true extent of interhospital variation after adjustment for more detailed clinical variables, as well as the specific timing of practice variation (preoperative versus intraoperative or postoperative). More importantly, randomized controlled trials are needed to evaluate the true efficacy of elective IABP use in selected CABG surgical patients. Until such studies are done, clinicians will continue to struggle with the difficult question of which rate is right. We acknowledge the support of Hude Quan, MD, PhD, (University of Calgary) in data management and analysis. This project was supported by the Massachusetts Health Data Consortium, and by a grant from the Walnut Medical Charitable Trust. Doctor Ghali is supported by a Population Health Investigator grant from the Alberta Heritage Foundation for Medical Research. References 1. Hannan EL, Kilburn H Jr, O Donnell JF, Lukacik G, Shilds EP. Adult open heart surgery in New York state: an analysis of risk factors and hospital mortality rates. JAMA 1990;264: O Connor GT, Plume SK, Olmstead EM, et al, for the Northern New England Cardiovascular Disease Study Group. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. JAMA 1991; 266: Hartz AJ, Kuhn EM. Comparing hospitals that perform coronary artery bypass surgery: the effect of outcome measures and data sources. Am J Public Health 1994;84: Silber JH, Rosenbaum PR, Schwartz JS, Ross RN, Williams SV. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA 1995;274: Huff ED. Have quality improvement efforts decreased mortality rates following cardiac surgery? JAMA 1997;277: Naylor CD. Assessing processes and outcomes of medical care. Ann R Coll Physicians Surg Can 1997;30: Kusiak VM, Goldberg S. Percutaneous intra-aortic balloon counterpulsation. Cardiovasc Clin 1985;15: Miller JS, Dodson TF, Salam AA, Smith RB. Vascular complications following intra-aortic balloon pump insertion. Am Surg 1992;58: Pennington DG, Swartz M, Codd JE, Merjavy JP, Kaiser GC. Intra-aortic balloon pumping in cardiac surgical patients: a nine-year experience. Ann Thorac Surg 1983;36: Densen PM, Fielding JE, Getson J, Stone E. The collection of data on hospital patients the Massachusetts Health Data Consortium approach. N Engl J Med 1980;302: International classification of diseases, ninth revision, clinical modification. Washington, DC: Public Health Services, US Department of Health and Human Services, Diagnosis related groups, version 10.0: definitions manual. Murray, UT: 3M Health Information Systems, Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325: Naylor CD, Levinton CM. Sex-related differences in coronary revascularization practices: the perspective from a Canadian queue management project. Can Med Assoc J 1993;149: Escarce JJ, Epstein KR, Colby DC, Schwartz JS. Racial differences in the elderly s use of medical procedures and diagnostic tests. Am J Public Health 1993;83: Young GJ, Cohen BB. Inequities in hospital care, the Massachusetts experience. Inquiry 1991;28: Gustensen J, Goldman BS, Scully HE, Huckell VF, Adelman AG. Evolving indications for preoperative intra-aortic balloon pump assistance. Ann Thorac Surg 1976;22: Bolooki H, Williams W, Thurer RJ, et al. Clinical and hemodynamic criteria for use of the intra-aortic balloon pump in patients requiring cardiac surgery. J Thorac Cardiovasc Surg 1976;72: Mundth ED. Preoperative intraaortic balloon pump assistance. Ann Thorac Surg 1976;22: Kaplan JA, Craver JM, Jones EL, Sumpter R. The role of the intra-aortic balloon in cardiac anesthesia and surgery. Am Heart J 1979;98: Dietl CA, Berkheimer MD, Woods EL, Gilbert CL, Pharr WF, Benoit CH. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less. Ann Thorac Surg 1996;62: Hall RE, Cohen MM. Variations in hysterectomy rates in Ontario: does the indication matter? Can Med Assoc J 1994; 151: Wennberg JE. The paradox of appropriate care. JAMA 1987; 258:
Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England
ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.
More informationIncreasing health care costs and a political movement toward balancing the budget
A case study of hospital and centralization of coronary revascularization procedures Brenda R. Hemmelgarn, * William A. Ghali, * Hude Quan * Abstract Background: Despite nation-wide efforts to reduce health
More informationTechnical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005
Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to
More informationSurgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac
More informationTrends in Intraaortic Balloon Counterpulsation Complications and Outcomes in Cardiac Surgery
Trends in Intraaortic Balloon Counterpulsation and Outcomes in Cardiac Surgery Jan T. Christenson, MD, Marc Cohen, MD, James J. Ferguson III, MD, Robert J. Freedman, MD, Michael F. Miller, PhD, E. Magnus
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationAttendance rates and outcomes of cardiac rehabilitation in Victoria, 1998
Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 CARDIOVASCULAR DISEASE is the leading cause of death in Australia, causing more than 40% of all deaths in 1998. 1 Cardiac rehabilitation
More informationPatients Treated by Cardiologists Have a Lower In-Hospital Mortality for Acute Myocardial Infarction
885 Patients Treated by Cardiologists Have a Lower In-Hospital Mortality for Acute Myocardial Infarction PAUL N. CASALE, MD, FACC, JAYNE L. JONES, MPH,* FLOSSIE E. WOLF, MS,* YANFEN PEI, MS,* L. MARLIN
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationBUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting
BUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting Arthur J. Hartz, MD, PhD, Evelyn M. Kuhn, PhD, Kenneth L. Kayser, MS, and W. Dudley Johnson, MD Department of Family and Communitv
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationIn two articles in this supplement [1, 2], the conceptual
Criteria by Which to Evaluate Risk-Adjusted Outcomes Programs in Cardiac Surgery Jennifer Daley, MD Health Services Research and Development and Department of Medicine, Brockton/West Roxbury Veterans Affairs
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationRisk Stratification Using The Society of Thoracic Surgeons Program
Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationPrediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm
Nephrol Dial Transplant (2003) 18: 77 81 Original Article Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Bjørn O. Eriksen 1, Kristel R.
More informationThe article by Stamou and colleagues [1] found that
THE STATISTICIAN S PAGE Propensity Score Analysis of Stroke After Off-Pump Coronary Artery Bypass Grafting Gary L. Grunkemeier, PhD, Nicola Payne, MPhiL, Ruyun Jin, MD, and John R. Handy, Jr, MD Providence
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationCoronary artery bypass grafting (CABG) is one of the most intensely scrutinized
Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie
More informationRates and patterns of participation in cardiac rehabilitation in Victoria
Rates and patterns of participation in cardiac rehabilitation in Victoria Vijaya Sundararajan, MD, MPH, Stephen Begg, MS, Michael Ackland, MBBS, MPH, FAPHM, Ric Marshall, PhD Victorian Department of Human
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationRisks of coronary artery bypass surgery in dialysis-dependent patients analysis of the 2001 National Inpatient Sample
NDT Advance Access published February 13, 2007 Nephrol Dial Transplant (2007) 1 of 7 doi:10.1093/ndt/gfl835 Original Article Risks of coronary artery bypass surgery in dialysis-dependent patients analysis
More informationModeling and Risk Prediction in the Current Era of Interventional Cardiology
Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.
More informationSince the late 1970s, numerous studies have appeared in
Relationship Between Provider Volume and Mortality for Carotid Endarterectomies in New York State Edward L. Hannan, PhD; A. John Popp, MD; Bruce Tranmer, MD; Paul Fuestel, PhD; John Waldman, MD; Dhiraj
More informationThe American Experience
The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationSurgery for Acquired Cardiovascular Disease
Surgery for Acquired Cardiovascular Disease Guru, Fremes, Tu Time-related mortality for women after coronary artery bypass graft surgery: A population-based study Veena Guru, MD a,b Stephen E. Fremes,
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationThe Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models
The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,
More informationOutcome after coronary artery bypass grafting
ICU Admission Score for Predicting Morbidity and Mortality Risk After Coronary Artery Bypass Grafting Thomas L. Higgins, MD, Fawzy G. Estafanous, MD, Floyd D. Loop, MD, Gerald J. Beck, PhD, Jar-Chi Lee,
More informationChapter 9: Cardiovascular Disease in Patients With ESRD
Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationCurrent use of preoperative intra-aortic balloon counterpulsation in high-risk cardiac surgery: a cohort study
Current use of preoperative intra-aortic balloon counterpulsation in high-risk cardiac surgery: a cohort study Ed Litton, Anthony Delaney, Judy M Simpson and Raymond Raper Intra-aortic balloon counterpulsation
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationEfficacy and Cost-Effectiveness of Preoperative IABP in Patients with Ejection Fraction of 0.25 or Less
Efficacy and Cost-Effectiveness of Preoperative IABP in Patients with Ejection Fraction of 0.25 or Less Charles A. Dietl, MD, Marie D. Berkheimer, RN, Edward L. Woods, MD, Christian L. Gilbert, MD, William
More informationA Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions
Journal of the American College of Cardiology Vol. 47, No. 3, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.09.071
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in
More informationCardiogenic Shock. Carlos Cafri,, MD
Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and
More informationComparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients
Journal of Preventive Medicine and Public Health January 2010, Vol. 43, No. 1, 42-49 doi: 10.3961/jpmph.2010.43.1.42 Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationFor several years, there has been considerable popular and
Waiting for Cardiac Surgery Results of a Risk-Stratified Queuing Process A. Andrew Ray, MSc; Karen J. Buth, MSc; John A. Sullivan, MD, FRCSC; David E. Johnstone, MD, FRCPC; Gregory M. Hirsch, MD, FRCSC
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationManagement of Cardiogenic shock. Prof. Christian JM Vrints
Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationCritical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery
Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery University of Ottawa Heart Institute Jean Yves Dupuis, MD, FRCPC Cardiac Division of Anesthesiology Disclosure
More informationIntra-aortic balloon counterpulsation in US and non-us centres: results of the Benchmark Registry. COHEN, Marc, et al. Abstract
Article Intra-aortic balloon counterpulsation in US and non-us centres: results of the Benchmark Registry COHEN, Marc, et al. Abstract To examine differences in patient characteristics and outcomes in
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationReport on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07
Evidence guiding health care Report on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07 In collaboration with the Cardiac Care Network of Ontario July 2008 Report on Coronary
More informationPredictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery
Birnie et al. Critical Care 2014, 18:606 RESEARCH Open Access Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery Kate Birnie 1, Veerle
More informationhad non-continuous enrolment in Medicare Part A or Part B during the year following initial admission;
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries Weiss J P, Saynina O, McDonald K M, McClellan M
More informationery: Comparison of Predicted and Observed Resu ts
Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,
More informationRACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION
RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION DANIEL L. DRIES, M.D., M.P.H., DEREK V. EXNER, M.D., BERNARD J. GERSH,
More informationArkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary
Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary Congestive Heart Failure Algorithm Summary v1.2 (1/5) Triggers PAP assignment Exclusions Episode time window
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationJournal of the American College of Cardiology Vol. 42, No. 10, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 10, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.05.007
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationPreoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting
Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Tuula S. O. Kurki, MD, and Matti Kataja, PhD Heart Center, Deaconess Hospital, and National Public Health Institute,
More informationOlder individuals are at greatest risk for developing and
Decade Long Trends (2001 2011) in Duration of Pre-Hospital Delay Among Elderly Patients Hospitalized for an Acute Myocardial Infarction Raghavendra P. Makam, MD, MPH; Nathaniel Erskine, BS; Jorge Yarzebski,
More informationThe development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction
TREATMENT UPDATE Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction David R. Holmes, Jr, MD Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN Cardiogenic shock is a serious
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationOut-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland
Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.
More informationAutomatic External Defibrillators
Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More informationPredictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years
Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti, MS, and Terrence M. Yau, MD, MS Division of Cardiovascular
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationInstitute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2
Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute
More informationThe emergence of health maintenance organizations
Predictors of 30-Day Hospital Readmission After Coronary Artery Bypass Robert D. Stewart, MD, Christian T. Campos, MD, Beth Jennings, BA, S. Scott Lollis, BA, Sidney Levitsky, MD, and Stephen J. Lahey,
More informationThe use of Intra Aortic Baloon Pump in Patients undergoing Coronary Artery Bypass Grafting at the Aga Khan University Hospital, Karachi
The use of Intra Aortic Baloon Pump in Patients undergoing Coronary Artery Bypass Grafting at the Aga Khan University Hospital, Karachi Aamir M. Jafarey,Muneer Amanullah,Sajid A. Khan,Sulaiman B. Hasan
More informationImpact of Hospital Volume on Racial Disparities in Cardiovascular Procedure Mortality
Journal of the American College of Cardiology Vol. 47, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.08.068
More informationPatient Characteristics Can Predict Improvement in Functional Health After Elective Coronary Artery Bypass Grafting
Patient Characteristics Can Predict Improvement in Functional Health After Elective Coronary Artery Bypass Grafting Karl F. Welke, MD, Jennifer P. Stevens, MS, William C. Schults, MS, Eugene C. Nelson,
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationLeft Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients
Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison
More informationSupplementary Text A. Full search strategy for each of the searched databases
Supplementary Text A. Full search strategy for each of the searched databases MEDLINE: ( diabetes mellitus, type 2 [MeSH Terms] OR type 2 diabetes mellitus [All Fields]) AND ( hypoglycemia [MeSH Terms]
More informationAppendix 1: Supplementary tables [posted as supplied by author]
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
More informationVariation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation
CARDIOVASCULAR Variation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation Dexiang Gao, PhD, Gary K. Grunwald, PhD, John S. Rumsfeld, MD, PhD, Todd Mackenzie, PhD, Frederick
More informationRapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible?
Rapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible? Richard A. Ott, MD, Dan E. Gutfinger, MD, PhD, Mark P. Miller, MD, Hossein Alimadadian, MD, and Teresa M. Tanner Division
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationA Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD
A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationA Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty
JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD
More informationTechnical Appendix for Outcome Measures
Study Overview Technical Appendix for Outcome Measures This is a report on data used, and analyses done, by MPA Healthcare Solutions (MPA, formerly Michael Pine and Associates) for Consumers CHECKBOOK/Center
More informationThe prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers
Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular
More informationTitle: Automatic External Defibrillators Division: Medical Management Department: Utilization Management
Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,
More informationInstitute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2
Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute
More information